Cleared Traditional

K240664 - ALARA BMA Neuro Access Kit (ALARA BMAN ...

K240664 is the FDA 510(k) clearance for ALARA BMA Neuro Access Kit (ALARA BMAN ... by SurGenTec, LLC. It is a Class 2 General & Plastic Surgery device (product code KNW) cleared through the Traditional 510(k) pathway after a 154-day FDA review.

K240664 · SurGenTec, LLC · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2024
Decision
154d
Days
Class 2
Risk

K240664 is an FDA 510(k) clearance for the ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit). Classified as Instrument, Biopsy (product code KNW), Class II - Special Controls.

Submitted by SurGenTec, LLC (Boca Raton, US). The FDA issued a Cleared decision on August 9, 2024 after a review of 154 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1075 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all SurGenTec, LLC devices

Submission Details

510(k) Number K240664 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 08, 2024
Decision Date August 09, 2024
Days to Decision 154 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d slower than avg
Panel avg: 115d · This submission: 154d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KNW Instrument, Biopsy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - KNW Instrument, Biopsy

All 156
Devices cleared under the same product code (KNW) and FDA review panel - the closest regulatory comparables to K240664.
Triopsy Actuator (TMSDGB)
K242228 · Triopsy Medical, Inc. · Jan 2025
Mammotome AutoCore™ Single Insertion Core Biopsy System
K243095 · Devicor Medical Products, Inc. · Oct 2024
TRAP EASY
K242029 · H.S Hospital Service S.P.A · Oct 2024
Automatic Biopsy Needle BAM, Semi-Automatic Needle BIM
K233294 · Itp Innovative Tomography Products GmbH · Jun 2024
M·Biopsy /SureCore Automatic Disposable Biopsy Needle, M·Biopsy /SureCore Semi-automatic Disposable Biopsy Needle, M·Biopsy /SureAim Coaxial Biopsy Needle
K233031 · Canyon Medical, Inc. · Jan 2024
SUREcore Prime Biopsy Instrument
K230646 · Uro-1 Medical, Inc. · Nov 2023